Schwarzwald-Baar Klinikum

Hospital


Location: Villingen-Schwenningen, Germany (DE) DE

ISNI: 0000000104139032

ROR: https://ror.org/0446n1b44

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214) (2024) Hofheinz RD, Herrle F, Dechow T, von Weikersthal LF, Welslau M, Lettmaier S, Burkart C, et al. Journal article 7. Ringversuch Arzneimittelinformation der ADKA (2024) Strobach D, Hehr J, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Rekonstruktion onkologischer Defekte im Becken-Perinealbereich – Bericht zum Konsensus-Workshop im Rahmen der 44. Jahrestagung der DAM 2023 in Bern, CH (2024) Kappos EA, Wendelspiess SR, Stoffel J, Djedovic G, Rieger UM, Bannasch H, Fritsche E, et al. Journal article Paravertebral fibrous pseudotumor: Four cases of a distinctive tumefactive lesion overlapping with eosinophilic angiocentric fibrosis and tumoral erythema elevatum diutinum (2023) Agaimy A, Förster S, Kalla J, Stacher-Priehse E, Titze U, Vieth M Journal article Digital emergency management in acute and emergency care networks. Delineation of key points by the ZTM expert council Digitales Notfallmanagement im Netzwerk der Akut- und Notfallversorgung. Eckpunktepapier des Expertenrats des ZTM (2023) Eder PA, Soda H, Kumle B, Dodt C, Dormann H, Popp E, Flasch B, et al. Journal article Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial (2022) Goerling U, Gauler T, Dietz A, Grünwald V, Knipping S, Guntinas-Lichius O, Frickhofen N, et al. Journal article Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial (2022) Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, et al. Journal article 5. Ringversuch Arzneimittelinformation der ADKA. Was ist wichtig bei der Bearbeitung von Anfragen zu Nebenwirkungen? (2022) Strobach D, Chiriac U, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial) (2022) Welsch T, Muessle B, Korn S, Sturm D, Bork U, Distler M, Graehlert X, et al. Journal article Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma (2021) Straka C, Salwender H, Knop S, Vogel M, Muller J, Metzner B, Langer C, et al. Journal article
1 2 3 4